Anthracycline derivative chemotherapeutic drugs inhibit UHRF1-SRA binding to hemimethylated DNA and synergize with known DNA methyltransferase inhibitors for cancer cell cytotoxicity. This evidence concerns the gene UHRF1 and cancer.